Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xin Zhou, Jin Shang, Xing Liu, Jin-Fu Zhuang, Yuan-Feng Yang, Yi-Yi Zhang & Guo-Xian Guan. (2021) Clinical Significance and Oncogenic Activity of GRWD1 Overexpression in the Development of Colon Carcinoma. OncoTargets and Therapy 14, pages 1565-1580.
Read now
Read now
Maria I Toki, Muhammad Wasif Saif & Kostantinos N Syrigos. (2014) Hypersensitivity reactions associated with oxaliplatin and their clinical management. Expert Opinion on Drug Safety 13:11, pages 1545-1554.
Read now
Read now
Nikos Maniadakis, Vasilios Fragoulakis, Dimitrios Pectasides & George Fountzilas. (2009) XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis. Current Medical Research and Opinion 25:3, pages 797-805.
Read now
Read now
Michele Santodirocco, Valentina Lombardi, Cinzia Fesce, Gaetano Palumbo, Silvana Capalbo & Matteo Landriscina. (2008) Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: A case report. Acta Oncologica 47:8, pages 1602-1604.
Read now
Read now
Articles from other publishers (17)
Kyung Sook Hong, Soon Sup Chung, Kwang Ho Kim & Ryung-Ah Lee. (2022) Efficacy of a rehabilitation program using minor muscles in colorectal cancer patients with chemotherapy-induced neuropathy: preliminary study. Korean Journal of Clinical Oncology 18:1, pages 11-16.
Crossref
Crossref
Alma Lucia Villela Zumaya, Silvie Rimpelová, Markéta Štějdířová, Pavel Ulbrich, Jarmila Vilčáková & Fatima Hassouna. (2022) Antibody Conjugated PLGA Nanocarriers and Superparmagnetic Nanoparticles for Targeted Delivery of Oxaliplatin to Cells from Colorectal Carcinoma. International Journal of Molecular Sciences 23:3, pages 1200.
Crossref
Crossref
James D. Hoeschele, Jana Kasparkova, Hana Kostrhunova, Olga Novakova, Jitka Pracharova, Paul Pineau & Viktor Brabec. (2020) Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl2] analogs. JBIC Journal of Biological Inorganic Chemistry 25:6, pages 913-924.
Crossref
Crossref
Andreas Argyriou. (2015) Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN). Toxics 3:2, pages 187-197.
Crossref
Crossref
Sang Hui ChuYoon Ju LeeYoung Joo LeeCharles S. Cleeland. (2015) Properties of the Measures to Assess Oxaliplatin-induced Peripheral Neuropathy: A Literature Review. Journal of Korean Academy of Nursing 45:6, pages 783.
Crossref
Crossref
Xi Tao Xu, Zhang Han Dai, Qi Xu, Yu Qi Qiao, Yan Gu, Fang Nie, Ming Ming Zhu, Jin Lu Tong & Zhi Hua Ran. (2013) Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers. Journal of Digestive Diseases 14:6, pages 288-298.
Crossref
Crossref
Ya-Hsu Yang, Jen-Kou Lin, Wei-Shone Chen, Tzu-Chen Lin, Shung-Haur Yang, Jeng-Kai Jiang, Shih-Ching Chang, Yuan-Tzu Lan, Chun-Chi Lin, Chueh-Chuan Yen, Cheng-Hwai Tzeng, Wei-Shu Wang, Huey-Ling Chiang, Chung-Jen Teng & Hao-Wei Teng. (2011) Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. Supportive Care in Cancer 20:7, pages 1491-1497.
Crossref
Crossref
David K. Lam & Brian L. Schmidt. 2012. Current Therapy In Oral and Maxillofacial Surgery. Current Therapy In Oral and Maxillofacial Surgery
92
101
.
Joan Elizabeth Cunningham, Teresa Kelechi, Katherine Sterba, Nikki Barthelemy, Paul Falkowski & Steve H. Chin. (2011) Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage). Supportive Care in Cancer 19:9, pages 1473-1476.
Crossref
Crossref
Oleg Y. Dmitriev. (2011) Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7BThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process.. Biochemistry and Cell Biology 89:2, pages 138-147.
Crossref
Crossref
C Sheridan, G Brumatti, M Elgendy, M Brunet & S J Martin. (2010) An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs. Oncogene 29:49, pages 6428-6441.
Crossref
Crossref
Lars Ekblad, Johan Kjellström & Anders Johnsson. (2010) Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells. Anti-Cancer Drugs 21:5, pages 523-531.
Crossref
Crossref
R.K. Ramanathan, M.L. Rothenberg, A. de Gramont, C. Tournigand, R.M. Goldberg, S. Gupta & T. André. (2010) Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. Annals of Oncology 21:4, pages 754-758.
Crossref
Crossref
R. Velasco & J. Bruna. (2010) Chemotherapy-induced peripheral neuropathy: An unresolved issue. Neurología (English Edition) 25:2, pages 116-131.
Crossref
Crossref
R. Velasco & J. Bruna. (2010) Neuropatía inducida por quimioterapia: un problema no resuelto. Neurología 25:2, pages 116-131.
Crossref
Crossref
Andreas A. Argyriou, Panagiotis Polychronopoulos, Gregoris Iconomou, Elisabeth Chroni & Haralabos P. Kalofonos. (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treatment Reviews 34:4, pages 368-377.
Crossref
Crossref
S. Choi & J.N. Myers. (2008) Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy. Journal of Dental Research 87:1, pages 14-32.
Crossref
Crossref